Related Experiment Videos
PCR analysis of dystrophin gene mutation and expression
J S Chamberlain1, N J Farwell, J R Chamberlain
1Institute for Molecular Genetics, Baylor College of Medicine, Houston, Texas 77030.
Abstract:
Duchenne muscular dystrophy (DMD) is caused by mutations that impair normal production of dystrophin in muscle and brain tissues. The dystrophin gene is expressed at extremely low levels in both humans and mice, which makes analysis of the 14kb mRNA a difficult task. In addition, 30% of all cases of DMD (and the genetic lesion in all three known mdx mouse models for DMD) are thought to arise from single base mutations, yet methods are not available to routinely identify and analyze these mutations and their effects on disease progression. We have been using the polymerase chain reaction (PCR) to analyze the expression of the murine dystrophin gene. A simple assay is described that distinguishes the murine dystrophin transcripts expressed from either the muscle or brain promoter. In addition, amplification of overlapping segments from the 5' end of the murine transcript has enabled the identification of DNA sequence variations between wild-type and mdx mice. These results demonstrate that the mutation in the original strain of mdx mice is distinct from those in two newer mdx isolates and that three independently isolated mdx mutants are available for study of DMD.
Insights
Researchers developed a polymerase chain reaction (PCR) assay to analyze dystrophin gene expression in mice. This method helps identify mutations causing Duchenne muscular dystrophy (DMD) and distinguishes between different mdx mouse models.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Duchenne muscular dystrophy (DMD) results from impaired dystrophin production, affecting muscle and brain.
- Low dystrophin gene expression levels complicate mRNA analysis.
- Single base mutations, common in DMD, are challenging to detect and analyze.
Purpose of the Study:
- To develop a polymerase chain reaction (PCR)-based method for analyzing murine dystrophin gene expression.
- To differentiate dystrophin transcripts from muscle and brain promoters.
- To identify DNA sequence variations in mdx mouse models of DMD.
Main Methods:
- Utilized polymerase chain reaction (PCR) for gene expression analysis.
- Developed a simple assay to distinguish muscle and brain dystrophin transcripts.
- Amplified overlapping segments of the 5' end of the murine dystrophin transcript.
Main Results:
- Successfully analyzed murine dystrophin gene expression using PCR.
- Established an assay to differentiate transcripts from muscle and brain promoters.
- Identified distinct DNA sequence variations between wild-type and mdx mice, differentiating mdx mouse models.
Conclusions:
- The developed PCR assay is effective for analyzing dystrophin gene expression and identifying mutations.
- The mutation in the original mdx mouse strain is distinct from newer isolates.
- Three independently isolated mdx mutants are available for studying Duchenne muscular dystrophy.